Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 5, August

Biomarkers and Multiple Drug Resistance in Breast Cancer

Volume:6   Issue: 5
Pp: 365-384
L. O'Driscoll and M. Clynes
DOI: 10.2174/156800906777723958
Published on: 01 March, 2012

Reversal of Resistance to Oxazaphosphorines

Volume:6   Issue: 5
Pp: 385-407
Jing Zhang, Quan Tian, Yi-Zhun Zhu, An-Long Xu and Shu-Feng Zhou
DOI: 10.2174/156800906777723967
Published on: 01 March, 2012

Ribonucleotide Reductase Inhibitors and Future Drug Design open access plus

Volume:6   Issue: 5
Pp: 409-431
J. Shao, B. Zhou, Bernard Chu and Y. Yen
DOI: 10.2174/156800906777723949
Published on: 01 March, 2012

Role of ABC Transporters in the Chemoresistance of Human Gliomas

Volume:6   Issue: 5
Pp: 433-445
Xavier Decleves, Alexandra Amiel, Jean-Yves Delattre and Jean-Michel Scherrmann
DOI: 10.2174/156800906777723930
Published on: 01 March, 2012

Radiation-Induced Bystander and other Non-Targeted Effects: Novel Intervention Points in Cancer Therapy?

Volume:6   Issue: 5
Pp: 447-454
Carmel Mothersill and Colin Seymour
DOI: 10.2174/156800906777723976
Published on: 01 March, 2012